Myeloma UK Policy: Working with the Pharmaceutical Industry

This document defines how we engage with the pharmaceutical industry. This will ensure we can withstand external scrutiny of our decisions and actions whilst at the same time allowing us freedom to work in a way which ultimately benefits myeloma patients and their families.